Validation, which is confirmatory

Size: px
Start display at page:

Download "Validation, which is confirmatory"

Transcription

1 Validation and Change Control By definition, validation is a snapshot in time. by Gamal Amer, Ph.D. Validation, which is confirmatory in nature, is defined by FDA as Establishing through documented evidence, a high degree of assurance that a specific process will consistently produce a product that meets its predetermined specifications and quality attributes. By definition, validation is a snapshot in time, demonstrating that if a given process/system is installed in a certain way and operated in a certain manner (according to an established procedure), it will perform accordingly and produce a product/result with certain characteristics. Since the pharmaceutical industry is continuously attempting to improve its process through implementing change to the process, it is important to ensure that the operation/system remains in a validated state through the strict implementation of a change control system. This article defines the validation process and explores the issues associated with changes in the manufacture of healthcare products, their implication on validation, and how to control these changes to ensure that the systems remain in a validated state and cgmp compliant. Validation and its Implementation Validation as a Means to Ensure the Consistency of the Processing Operation In conducting a validation of a process or a system, the industry standard is to prepare protocols to be followed. These protocols are usually referred to as Installation Qualification (IQ), Operation Qualification (OQ), and Performance Qualification (PQ). The Process Validation (PV) protocol is normally used to validate an entire process comprised of various systems/equipment operating in tandem, producing the specific product. The use of a validation protocol is now required by the regulation. 1 The proposed regulation defines a validation protocol as a written plan describing the process to be validated, including production equipment and how validation will be conducted. Such a plan would address objective test parameters, product and process characteristics, predetermined specifications, and factors which will determine acceptable results. As the validation effort progresses, one can identify specific activities which must take place. These are: 4 Institute of Validation Technology

2 Preparation of a validation master plan. 2 Collection and/or insuring the availability of all the critical documents required 3 for a successful validation effort. Preparation of the appropriate validation protocols. Execution of all relevant protocols. Preparation of final reports summarizing the results of the validation. Ensure that the process/systems remain in a validated state and in continuous compliance with cgmp requirements. This is normally accomplished using a change control procedure. Protocol Preparation A well-documented protocol is the first step in the validation effort and serves as a record that the equipment performed properly. The rigorous nature of the validation effort requires the completion of qualification protocols that serve as the procedure to be followed, providing a step-by-step set of instructions to perform the validation. In addition, the protocol provides a place where the test findings are recorded and supporting documents are stored. These qualification protocols can be prepared as IQ, OQ, PQ, or combinations thereof. Since the process validation normally depends on the specific process configuration, a separate protocol is normally developed for this ultimate activity. The PV protocol is usually executed once all subsystems have been validated/qualified. Figure 1 depicts an example table of contents of a typical protocol. The IQ protocol is written with the objective of confirming the following aspects for each individual critical system/piece of equipment: Fabrication or construction meeting user s specifications and applicable codes as well as cgmp requirements The existence of correct as-built drawings for the critical equipment and supplies for the process as well as the critical utilities Availability and qualification of utilities at points of use specified Presence of operation, maintenance, and cleaning manuals or substitute written procedures should manuals not be available Defined preventive maintenance and calibration schedule Figure 1 Example Table of Contents for a Validation Protocol 1.0 Approvals 2.0 Purpose and Objectives 3.0 Equipment/System Descriptions 4.0 Responsibilities 5.0 References 6.0 Validation Methodology 7.0 Acceptance Criteria 8.0 Procedures and Data Tables 9.0 Final Report and Approvals 10.0 Appendices Completeness of the documentation of system construction by reviewing the following (consult reference three for more details): training records, change controls, submittals, punch lists, weld logs, pressure leak tests, cleaning and passivation records, startup certification, instrument inventory, calibration, loop check, manuals, drawings, specifications, and purchase orders The OQ protocol is written with the objective of confirming the following aspects for each individual critical system/piece of equipment: Compliance of deliverables purchased or site erected to user s specifications as promised by the supplier and described in applicable codes and standards for operation, maintenance, calibration, and cleaning System operation within predetermined and approved acceptance criteria The PQ/PV documents are written with the objective of confirming the following aspects for each individual critical system or the entire process: Performance of a system is reproducible over an extended period of time. An example would be to demonstrate that a purified water system is capable of producing water that consistently meets biological and chemical standards established by the United States Pharmacopoeia (USP) Process performance such as the ability of a certain processing sequence to produce a product within predetermined and approved acceptance criteria Special Edition: Change Control 5

3 Protocol Execution Once the protocols are prepared, reviewed, and approved by the appropriate units within the organization, the equipment/system is validated through: Performing the activities identified in the approved protocols Ensuring that all instrumentation, either used in the validation effort or associated with the equipment and critical to its operation, is calibrated and has certificates traceable to National Institute of Standards and Technology (NIST) (or equivalent) standard (this is a specific requirement of the regulations) Sufficient qualified personnel are used during the execution of the protocols (a regulatory requirement) Proper analysis of samples and monitoring of critical parameters is performed as part of the protocol execution Summary Report/Final Validation Report Preparation Upon successfully completing protocol execution in the field, final reports are prepared. These reports summarize the results of the protocol execution and report findings in writing to the user. The reports follow a similar format to the protocols. Following report approval, all executed protocols, product related literature, and analytical results are packaged together and represent the overall validation record. rmally, a final process validation report would be prepared which summarizes what transpired during the validation effort and the efforts main findings and conclusions. A Validation Procedure The following is an outline of a proposed validation procedure developed based on the discussion presented above. In this procedure, I suggest names for groups within an organization, which would have specific responsibilities. It is understood that responsibilities associated with the validation effort will change from one company to the next. However, the names of departments/organizations presented in this example procedure are used in many companies and appear to be developing into an industry standard. ❶ Preparation of the Validation Master Plan (VMP): The first step in the validation procedure is to develop a VMP. This issue has been discussed at length in a previous article. 2 ❷ Protocol development: The next step in implementing a validation program is development of appropriate protocols as outlined in the VMP. These may simply be standard protocols with or without some modification or newly developed protocols. The validation group, with the help of the engineering group, normally prepares protocols for IQ and OQ. On the other hand, the validation group will prepare the PQ with the help of the user group. The user group, engineering, QA, and the validation group should then approve the protocols. I recommend that personnel approving the initial protocols be the ones who review and approve the executed protocols and final reports. ❸ Protocol Execution: Because of the engineering nature of the IQ, I recommend the validation group execute it while being assisted by the engineering department. For the OQ, the validation group should conduct the execution using normal operators, while for PQ execution, the validation group should manage the execution effort while the user group personnel perform the necessary activities. ❹ Data Collection and Final Report Preparation: This activity should be relegated to the validation group which collects the data, conducts the proper analysis of the data, reaches the proper conclusions, and prepares the final report. ❺ Approval of Final Report and Archiving the Documents: The final report is normally reviewed and approved by the user group, engineering, QA, and the validation group. It is recommended that the protocol with the associated report (and all documentation associates with it) be filed in a central file where all validation documents are stored. This central file should be either in the QA department or with the validation group. Controlled copies of the documents can be distributed to interested parties. This procedure is depicted in Figure 2. Change and Change Control The Need for Change w, as we all know, changes to the process are always occurring due to regulatory, economical, technical, and/or safety reasons. However, one should be aware of what the previous section indi- 6 Institute of Validation Technology

4 Figure 2 Activity Design Review Validation Procedure VMP 2 Protocol Preparation Protocol Execution Summary Report Preparation Validation Record IQ, OQ, PQ Executed IQ, OQ, PQ Validation Reports Example Documents Requirements 3 Engineering Drawings Specifications Manuals and ID SOPs Weld Logs, Certifications, Analytical, and Integrity Tests Product Data cates, namely, that validation is part of the overall requirements to adhere to cgmp. It further indicates that validation is a snapshot in time indicating that the equipment/process installed and operated in a certain way will continue to consistently produce a specific product, which meets its predetermined quality attributes, if and only if: ❶ Equipment/process has been installed in a certain fashion and the installation is not altered from the installation used during the IQ, is properly connected to required utilities, and connected to other pieces of equipment within a process sequence according to the design. ❷ Equipment/process is continually maintained according to appropriate procedures defined by the manufacturer. ❸ All of its controllers are calibrated and maintained according to manufacturer recommendations. ❹ Equipment/process is operated according to specific Standard Operating Procedures (SOPs) which were used during the validation effort and that the personnel operating it are properly trained. ❺ The raw materials and other inputs to the process are consistent and not altered from the inputs used during the validation effort itself. In short, the process, once validated, will remain validated and in compliance with cgmp if the equipment is maintained and operated in the manner that was in effect when the validation was conducted. It is important that whenever a change is contemplated to the system or one of its components, that it be evaluated to determine the impact of the change on the GMP compliance and validation status of the system as a whole. Once such a review is completed, an educated assessment as to whether or not revalidation is required can be made. Other GMP compliance actions can also be defined based on the review, such as updating the SOP, modifying a maintenance procedure, or making additional changes to the process to insure that it remains in compliance with cgmp requirements. The industry practice, as well as the regulatory requirement, 1 is the use of a change control procedure/measures. Types of Changes Changes can be divided into two categories depending on the timing of the change. A. Planned Changes: changes that would improve operations. Such changes have normally been studied and justified and all interested parties are in agreement that it would be beneficial to implement. In addition, one could envision routine maintenance changes as being planned changes, well known in advance, and everyone believes they should be done. B. Emergency Changes: Changes performed on an emergency basis to ensure continued operation of the system. Changes, either planned or emergency, can further be divided into two categories based on the types of systems requiring the change. These are: ❶ Facility/Utility type changes: These are changes which are to be made to a facilityrelated component, such as changing the positions of a door, the type of wall finish used, or modifying the layout of the manufac- Special Edition: Change Control 7

5 turing space. On the other hand, utility system changes could be related to modification to an existing water system, Heating, Ventilation, and Air Conditioning (HVAC) system, compressed air system, steam generating system, house vacuum system, etc. ❷ Equipment/processing changes: These are changes made in the equipment utilized in the manufacture of a drug product, such as substituting one type of filter with another or using a larger tank to conduct a reaction other than the one originally installed. Processing changes could include changing the temperature at which a given reaction is conducted to the changing of a raw material that is used in the process. Finally, all changes can be viewed from the point of view of their impact on cgmp as either: a. Major changes: These are changes which have the greatest possible impact on the GMP compliance of the process/facility used in the manufacture of the product. The impact will arise from the fact that the change would have the potential of affecting the quality, efficacy, or safety of the product. Examples of major changes include extending the loop of a given WFI system to service another building not anticipated in the original design, changing the raw material used in the production of a drug to a different grade, modifying the layout of a clean room (class 100), adding a step to the operation or making significant changes to the processing procedure. Such changes should be reviewed very carefully, and an appropriate strategy to address the GMP implication should be devised. b. Minor changes: These are changes which would have no impact on the quality, safety, and efficacy of the product and, therefore, would not affect the GMP compliance status of the facility/process. Examples of such changes include exchanging a process pump with the same exact pump (inkind) without modifications to the piping or the operation, increasing the flow rate of a stream without going outside the original validated, or regulatory approved, range, changes performed on noncritical systems 2 which were not validated initially, or changing a leaky valve in-kind for the HVAC humidifier. Change Control Procedure Change control is not used to prevent change, but rather, as the name implies, control it. The idea is that through the use of a simple procedure, an organization will ensure that any changes to a GMP system/process will not go unnoticed, and their effect on validation and GMP compliance will be addressed prior to implementing the change and making it permanent. The following represents an outline for a proposed change control procedure. This procedure is based on discussions with many industry professionals involved in validation and GMP compliance and is based on certain assumptions of organizational structure. Some of the department names presented in this example procedure may not represent actual situations in a given company. However, the main issues and divisions outlined in the example appear to be universal. ❶ Initiating a change: The first step in attempting to implement a change is to request a change be reviewed and approved by all interested parties. This can be achieved by the person/group requesting the change using a change request form. The change request form will contain the following information: Reason and justification for requesting change Technical information necessary to implement change Drawings and sketches ❷ Review: The change request form is then reviewed by a group comprised of the user group (operations), engineering, Quality Assurance (QA), and the validation group. In addition, representatives from the safety and environmental groups should participate in such a review. ❸ Identify GMP implications: As part of the change approval process, both QA and the validation group render an opinion regarding whether or not the change would impact the cgmp status of the system. If it does impact 8 Institute of Validation Technology

6 the system s cgmp status, then an opinion is rendered regarding whether or not requalification/revalidation of the system is required. The change request is then approved with the proviso that certain GMP compliance requirements be satisfied prior to making the change permanent. ❹ Identify Revalidation Requirements: Should requalification/revalidation be the requirement, the system is requalified and or revalidated according to the validation procedure described earlier in this article. Of course, the implementation of the change will take place after the protocols have been developed, and the protocols will be executed once the change has been made to the system but prior to making the change permanent. ❺ Making the change permanent: Once the change is made and adequately validated and is demonstrated to comply with GMP requirements, it becomes permanent, which means that the change is now part of the normal operation. Should a need to revert to the original state of the operation arise, the system is changed again using the change control procedure. Figure 3 graphically depicts this change control procedure. Implementing the Change Once the change control request is approved and the consequences of the change are defined, an implementation plan is developed, and the change is implemented according to a defined schedule. Necessary GMP compliance-related issues are addressed as part of the change implementation exercise. Many situations could arise and require attention from the quality unit and validation groups within the organization. For example, in the case of emergency changes, the change has probably occurred while no one was around. In such a situation, a request has to be filed immediately. Review of the request should be conducted within a very short period of time and, it is key in this case to, obtain quick approval and define all cgmp actions required immediately. Should requalification be required, it should be done quickly to allow for the continued operation of the facility/system. Conversely, in the case of planned changes, adequate time was available to review, document, and validate the change. rmally the appropriate individuals are involved early in the process and agreement is reached prior to the actual implementation. Major changes to facilities, utilities, or equipment, which have a cgmp implication, normally require requalification. On the other hand, minor changes to these systems only require a review by interested parties to confirm that no requalification is needed. Generally, the responsibility of implementing changes associated with the facility/utility lies with the facilities engineering department. It is also their responsibility to ascertain that the systems/facility is continually in a validated state. rmally, for equipment-associated changes, the user group/equipment owner is responsible for alerting appropriate parties of the change and making sure that the change is properly done. It is also their responsibility to ascertain that the equipment is always in a validated state. Finally, I have found that one of the major problems faced by pharmaceutical companies in cgmp compliance is the lack of appreciation, by most people involved, of the importance of adhering to change control policies and procedures. I believe that regular training of mechanics, maintenance personnel, engineers, and operators is essential to raising the awareness level regarding change control and improving cgmp compliance. In Summary Validation is a GMP requirement. Implementation requires the use of validation protocols. The industry standard is to use Installation, Operation, and Performance Qualification (IQ, OQ, PQ) protocols. In order to ensure that a validated system remains in compliance with GMP and in a validated state, regardless of changes which may be done to it, a change control system must be implemented. Change control is achieved using a procedure and is invoked each time a change to the system is contemplated. A change control procedure is a tool to make sure facilities and systems remain in a validated state as well as in compliance with cgmp requirements and should not be used to discourage change. The procedure should be kept simple and easy to follow to ensure that it is always used. The objective is to ascertain that all appropriate personnel are informed of a pending change and have the opportunity to review the change and make an assessment as to Special Edition: Change Control 9

7 Figure 3 Change Control Procedure Change Required Generate Change Requested GMP Implications? Implement Change End Requalification Revalidation Required? Implement Change Prepare, Update, or Retrieve Protocols Prepare GMP Report Review/Obtain Approvals Obtain Approvals End Make Change and Execute Protocols Prepare Report Review Systems Adequately Qualified Obtain Approvals Change is Permanent End 10 Institute of Validation Technology

8 whether or not revalidation or other actions are required to ensure its continued compliance with GMP regulations. References 1. Food & Drug Administration, 21 CFR Parts 210 & 211, Proposed Rule, Federal Register, Friday, May 3, 1996, Docket # 95N Amer, G. (1999), Validation Master Planning: A Practical Guide for Development, Journal of Validation Technology, Vol. 5, Amer, G. (1999), Critical Documentation Requirements in Validation, Journal of Validation Technology, Vol. 5,. 3. Special Edition: Change Control 11

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control

More information

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management

More information

Guidance on Qualification of existing facilities, systems, equipment and utilities

Guidance on Qualification of existing facilities, systems, equipment and utilities QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 1 / 16 1. Acknowledgement...3 2. Introduction...3 3. Scope...4 4. Regulatory requirements...4 5. Guidance...4 5.1 Risk Assessment... 4 5.2 Procedure... 7 5.3

More information

OPERATIONAL STANDARD

OPERATIONAL STANDARD 1 of 11 1. Introduction The International Safe Transit Association (ISTA), a non-profit association whose objective is to prevent product damage and excess packaging usage within the distribution environment.

More information

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known

More information

White paper: FDA Guidance for Industry Update Process Validation

White paper: FDA Guidance for Industry Update Process Validation White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,

More information

Process Validation: Practical Aspects of the New FDA Guidance

Process Validation: Practical Aspects of the New FDA Guidance Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory

More information

Testing Automated Manufacturing Processes

Testing Automated Manufacturing Processes Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:

More information

Why System Suitability Tests Are Not a Substitute for Analytical Instrument Qualification

Why System Suitability Tests Are Not a Substitute for Analytical Instrument Qualification White paper System Suitability Tests and AIQ R.D.McDowall PhD Principal, McDowall Consulting Paul Smith European Validation Program Manager, PerkinElmer Nicola Vosloo PhD European Market Development Leader,

More information

Validation of process gas systems

Validation of process gas systems Validation of Process Gas Systems By Jeff Hargroves Alza Corporation Validation of process gas systems involve documenting the expected system behavior, and verifying that the system performs as expected.

More information

What is Process Validation?

What is Process Validation? What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process

More information

1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.

More information

FDA Guidance for Industry Update - Process Validation

FDA Guidance for Industry Update - Process Validation FDA Guidance Update: Process Validation: General Principles and Practices White Paper FDA Guidance for Industry Update - Process Validation The changing face of Validation; are IQ, OQ and PQ really dead

More information

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/INF 11/2015 1 April 2015 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * * Entry into force:

More information

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process

More information

Software. For the 21 CFR Part 11 Environment. The Science and Technology of Small Particles

Software. For the 21 CFR Part 11 Environment. The Science and Technology of Small Particles Software For the 21 CFR Part 11 Environment The Science and Technology of Small Particles 21 CFR Part 11 Solution confirm Software The Code of Federal Regulations Title 21, Part 11, was implemented by

More information

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories

More information

Annex 4 Supplementary guidelines on good manufacturing practices: validation

Annex 4 Supplementary guidelines on good manufacturing practices: validation World Health Organization WHO Technical Report Series, No. 937, 2006 Annex 4 Supplementary guidelines on good manufacturing practices: validation 1. Introduction 2. Scope 3. Glossary 4. Relationship between

More information

New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2

New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2 New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2 This white paper describes the changes outlined in the Draft International Standard (DIS) editions of ISO 14644-1 and ISO 14644-2.

More information

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human

More information

The SaaS LMS and Total Cost of Ownership in FDA-Regulated Companies

The SaaS LMS and Total Cost of Ownership in FDA-Regulated Companies The SaaS LMS and Total Cost of Ownership in FDA-Regulated Companies The SaaS LMS and Total Cost of Ownership in FDA-Regulated Companies By Rob Sims, Director, Life Science, UL EduNeering When a Life Science

More information

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Working document QAS/03.055/Rev.2 RESTRICTED SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION This document has followed

More information

FDA 21 CFR Part 11 Electronic records and signatures solutions for the Life Sciences Industry

FDA 21 CFR Part 11 Electronic records and signatures solutions for the Life Sciences Industry FDA 21 CFR Part 11 Electronic records and signatures solutions for the Life Sciences Industry The Rule 21 CFR Part 11 Handwritten signature means the scripted name or legal mark of an individual handwritten

More information

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

On-Site Risk Management Audit Checklist for Program Level 3 Process

On-Site Risk Management Audit Checklist for Program Level 3 Process On-Site Risk Management Audit Checklist for Program Level 3 Process Auditor name: Date: I. Facility Information: Facility name: Facility location: County: Contact name: RMP Facility I.D. Phone Number:

More information

Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities

Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities September 2, 2003 Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities Purpose This document provides a summary of the requirements relating to use of computer-based systems in activities

More information

Computer System Validation - It s More Than Just Testing

Computer System Validation - It s More Than Just Testing Computer System Validation - It s More Than Just Testing Introduction Computer System Validation is the technical discipline that Life Science companies use to ensure that each Information Technology application

More information

Implementing New USP Chapters for Analytical Method Validation

Implementing New USP Chapters for Analytical Method Validation Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: Ludwig_Huber@labcompliance.com Today s Agenda Handling Method Changes vs. Adjustments

More information

In 2001, ISPE issued Baseline Guide Volume

In 2001, ISPE issued Baseline Guide Volume In today s biopharma and pharmaceutical industries, three related, but distinct terms are in common use: commissioning, qualification, and verification. Inconsistent interpretation and application of these

More information

AN OVERVIEW OF PHARMACEUTICAL VALIDATION: QUALITY ASSURANCE VIEW POINT

AN OVERVIEW OF PHARMACEUTICAL VALIDATION: QUALITY ASSURANCE VIEW POINT INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Review Article AN OVERVIEW OF PHARMACEUTICAL VALIDATION: QUALITY ASSURANCE VIEW POINT L. Nandhakumar*, G. Dharmamoorthy,

More information

Computer-Aided Facilities Management - A Logical Trend

Computer-Aided Facilities Management - A Logical Trend Computer-Aided Facilities Management - A Logical Trend Two major organisational changes are part of the modern pharmaceutical industry scene. Firstly, mergers as companies seek to consolidate resources

More information

Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries

Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries White Paper No 01 I December 2010 Implementation of 21 CFR Part 11 in the epmotion Software Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device

More information

Installation, Operation and Performance Qualification of a Thermoguard Installation

Installation, Operation and Performance Qualification of a Thermoguard Installation Installation, Operation and Performance Qualification of a Thermoguard Installation Thermoguard Qualification in Accordance with GMP To operate Thermoguard hardware and software within a regulated environment

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

The FDA recently announced a significant

The FDA recently announced a significant This article illustrates the risk analysis guidance discussed in GAMP 4. 5 By applying GAMP s risk analysis method to three generic classes of software systems, this article acts as both an introduction

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

Building Commissioning 17900-1

Building Commissioning 17900-1 SECTION 17900 BUILDING COMMISSIONING PART 1 - GENERAL 1.01 WORK DESCRIPTION: A. General: 1. The Commissioning process is a joint team effort to ensure that all mechanical equipment, controls, and systems

More information

Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements

Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements / WHITE PAPER Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements The 21 CFR Part 11 rule states that the FDA view is that the risks of falsification, misinterpretation,

More information

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. Supplier Quality Standard 1.0 Purpose The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. These expectations

More information

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes

More information

Particle Monitoring Requirements in Pharmaceutical Cleanrooms

Particle Monitoring Requirements in Pharmaceutical Cleanrooms Particle Monitoring Requirements in Pharmaceutical Cleanrooms All drugs must be manufactured in accordance with the current Good Manufacturing Practice (cgmp) regulations. Pharmaceutical manufacturers

More information

21 CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES 21.11.2013. 21 CFR Part 11 Compliance PLA 2.1

21 CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES 21.11.2013. 21 CFR Part 11 Compliance PLA 2.1 21 CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES Compliance of PLA 2.1 21.11.2013 21 CFR Part 11 Compliance PLA 2.1 SEC. 11.2 IMPLEMENTATION. (a) For records required to be maintained but not submitted

More information

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal

More information

A WHO guide to good manufacturing practice (GMP) requirements

A WHO guide to good manufacturing practice (GMP) requirements WHO/VSQ/97.02 ENGLISH ONLY DISTR.: LIMITED A WHO guide to good manufacturing practice (GMP) requirements Part 2: Validation Written by: Gillian Chaloner-Larsson, Ph.D, GCL Bioconsult, Ottawa Roger Anderson,

More information

White paper: The 10 Golden Rules of GMP

White paper: The 10 Golden Rules of GMP White paper: The 10 Golden Rules of GMP The Good Manufacturing Practice regulations that govern pharmaceutical and medical device manufacturing can seem overwhelming. Use these ten golden rules to drive

More information

Monitoring manufacturing, production and storage environments in the pharmaceutical industry

Monitoring manufacturing, production and storage environments in the pharmaceutical industry Application Description AD/RandC/005-EN Monitoring manufacturing, production and storage environments in the pharmaceutical industry - Provides independent verification and validation of the manufacture,

More information

Full Compliance Contents

Full Compliance Contents Full Compliance for and EU Annex 11 With the regulation support of Contents 1. Introduction 2 2. The regulations 2 3. FDA 3 Subpart B Electronic records 3 Subpart C Electronic Signatures 9 4. EU GMP Annex

More information

Classification and Qualification STANDARDS

Classification and Qualification STANDARDS Classification and Qualification STANDARDS HVAC Series Classification Title Class Code Date Established Date Revised Operating Engineer Building Service Engineer Air Conditioning/Refrigeration Mechanic

More information

Approaching the Response to Audit Observations

Approaching the Response to Audit Observations Introduction Approaching the Response to Audit Observations One of the first things consistently drilled into my collective memory was the statement that we should always be prepared for an audit. It was

More information

Validated SaaS LMS SuccessFactors Viability

Validated SaaS LMS SuccessFactors Viability Validated SaaS LMS SuccessFactors Viability Executive Summary SuccessFactors has a long history of working with validated organizations and has brought this expertise to their validated SaaS LMS package.

More information

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg Principles of Pharmaceutical Facility Design Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new

More information

21 CFR Part 11 Compliance Using STATISTICA

21 CFR Part 11 Compliance Using STATISTICA 21 CFR Part 11 Compliance Using STATISTICA Last Updated: April 2003 This document was updated to reflect the FDA s latest guidance (released February, 2003) and the withdrawal of previous guidance.! STATSOFT

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064587 EudraLex The Rules Governing Medicinal Products

More information

AS9100 Quality Manual

AS9100 Quality Manual Origination Date: August 14, 2009 Document Identifier: Quality Manual Revision Date: 8/5/2015 Revision Level: Q AS 9100 UNCONTROLLED IF PRINTED Page 1 of 17 1 Scope Advanced Companies (Advanced) has established

More information

Validation and Calibration. Definitions and Terminology

Validation and Calibration. Definitions and Terminology Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an

More information

FAT Factory Acceptance Testing SAT Site Acceptance Testing

FAT Factory Acceptance Testing SAT Site Acceptance Testing FAT Factory Acceptance Testing SAT Site Acceptance Testing Dr. Ingrid Walther May 2015, Page 1 Factory Acceptance Testing - FAT Site Acceptance Testing - SAT FAT and SAT - Important Milestones in the Project

More information

Haulsey Engineering, Inc. Quality Management System (QMS) Table of Contents

Haulsey Engineering, Inc. Quality Management System (QMS) Table of Contents Haulsey Engineering, Inc. Quality Management System (QMS) Table of Contents 1.0 Introduction 1.1 Quality Management Policy and Practices 2.0 Quality System Components 2.1 Quality Management Plans 2.2 Quality

More information

InfinityQS SPC Quality System & FDA s 21 CFR Part 11 Requirements

InfinityQS SPC Quality System & FDA s 21 CFR Part 11 Requirements InfinityQS SPC Quality System & FDA s 21 CFR Part 11 Requirements www.infinityqs.com Copyright InfinityQS International Table of Contents Overview... FDA s 21 CFR Part 11 Requirements... PART 11 ELECTRONIC

More information

Manual 074 Electronic Records and Electronic Signatures 1. Purpose

Manual 074 Electronic Records and Electronic Signatures 1. Purpose 1. Purpose The purpose of this document is to provide an interpretation of FDA 21 CFR Part 11, Electronic Records; Electronic Signatures (ER/ES) and to provide guidance for acceptable practices in the

More information

OPER H6001. Pharmaceutical Operations Mgt. APPROVED. Pharmaceutical Operations Management for Engineers. Credits: 5. NFQ Level: 9

OPER H6001. Pharmaceutical Operations Mgt. APPROVED. Pharmaceutical Operations Management for Engineers. Credits: 5. NFQ Level: 9 Short Title: Full Title: APPROVED Management for Engineers Module Code: OPER H6001 Credits: 5 NFQ Level: 9 Field of Study: Mechanics and metal work Module Delivered in 1 programme(s) Reviewed By: GERARD

More information

Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III

Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III BY DAVID W. VINCENT AND HERBERT MATHESON HEATING, VENTILATION, AND AIR CONDITIONING (HVAC) SYSTEMS INTRODUCTION

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

Considerations When Validating Your Analyst Software Per GAMP 5

Considerations When Validating Your Analyst Software Per GAMP 5 WHITE PAPER Analyst Software Validation Service Considerations When Validating Your Analyst Software Per GAMP 5 Blair C. James, Stacy D. Nelson Introduction The purpose of this white paper is to assist

More information

Annex 7 Guidelines on pre-approval inspections

Annex 7 Guidelines on pre-approval inspections World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the

More information

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality

More information

Public Cord Blood Bank

Public Cord Blood Bank The The Public Cord Blood Bank Page 1 of 21 TABLE OF CONTENTS INTRODUCTION... 3 WHAT ARE GOOD MANUFACTURING PRACTICES?... 5 1 TOTAL QUALITY... 7 2 PREMISES... 8 3 EQUIPMENT AND MATERIAL... 9 4 PERSONNEL...

More information

Risk-Based Validation of Commercial Off-the-Shelf Computer Systems

Risk-Based Validation of Commercial Off-the-Shelf Computer Systems Risk-Based Validation of Commercial Off-the-Shelf Computer Systems Published by Advanstar Communications in Journal of Validation Technology May 2005, Vol. 11, No. 3 Supplied by (*) www.labcompliance.com

More information

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR WHO/FWC/IVB/QSS/VQR 2011 This guidance document GUIDE TO MASTER FORMULAE is one of a series developed by WHO/FWC/IVB Quality, Safety & Standards team upon request from the manufacturers members of the

More information

ABSTRACT INTRODUCTION WINDOWS SERVER VS WINDOWS WORKSTATION. Paper FC02

ABSTRACT INTRODUCTION WINDOWS SERVER VS WINDOWS WORKSTATION. Paper FC02 ABSTRACT Paper FC02 Implementing SAS using Microsoft Windows Server and Remote Desktop Paul Gilbert, DataCeutics, Inc., Pottstown, PA Steve Light, DataCeutics, Inc., Pottstown, PA DataCeutics provides

More information

Regulatory Asset Management: Harmonizing Calibration, Maintenance & Validation Systems

Regulatory Asset Management: Harmonizing Calibration, Maintenance & Validation Systems Regulatory Asset Management: Harmonizing Calibration, Maintenance & Validation Systems 800.982.2388 1 Introduction Calibration, maintenance and validation activity, despite operating within the same department

More information

This interpretation of the revised Annex

This interpretation of the revised Annex Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation

More information

Design, Operation and Management of GTP/GMP Cell Engineering Facilities

Design, Operation and Management of GTP/GMP Cell Engineering Facilities Design, Operation and Management of GTP/GMP Cell Engineering Facilities Scott R. Burger, MD Advanced Cell & Gene Therapy BFDA 2007 International Symposium on Regulation of Human Cell and Tissue- Based

More information

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

GENERAL WELDING & FABRICATING, INC. 991 Maple Road Elma, New York 14059

GENERAL WELDING & FABRICATING, INC. 991 Maple Road Elma, New York 14059 QUALITY MANUAL GENERAL WELDING & FABRICATING, INC. 991 Maple Road Elma, New York 14059 Distribution: Position Location Copy # President / CEO Office 1 Operations Manager Office 2 Quality Assurance Office

More information

How to implement a Quality Management System

How to implement a Quality Management System How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your

More information

To help you understand the role documents and records play in the quality system and the monitoring of programs.

To help you understand the role documents and records play in the quality system and the monitoring of programs. Module 15 Documents and Records Purpose Pre-requisite Modules Learning Objectives Content Outline Handout Notes on Customization To help you understand the role documents and records play in the quality

More information

Monitoring the autoclaving process in the pharmaceutical industry

Monitoring the autoclaving process in the pharmaceutical industry Application Description AD/RandC/006-EN Monitoring the autoclaving process in the pharmaceutical industry - Provides independent verification and validation monitoring of the autoclaving process - Enables

More information

Workflow System for Paperless Air Monitoring Powered by MODA. Presented by

Workflow System for Paperless Air Monitoring Powered by MODA. Presented by Introducing Hach s MET ONE Compliance Workflow System for Paperless Air Monitoring Powered by MODA Presented by Scott Hjelmervik Bob Toal Systems Director Vice President Hach Company MODA Technology Partners

More information

Laboratory Information Management System

Laboratory Information Management System Laboratory Information Management System Lab Inventory Statistical Process Control LIMS Calibration Stability Dispensing Reagents Management Instrument Interfacing ERP Interface Complaint Tracking Process

More information

Guidelines for Validation & Qualification, including Change Control, for Hospital Transfusion Laboratories

Guidelines for Validation & Qualification, including Change Control, for Hospital Transfusion Laboratories Guidelines for Validation & Qualification, including Change Control, for Hospital Transfusion Laboratories British Committee for Standards in Haematology Address for correspondence: BCSH Secretary British

More information

GAMP5 - a lifecycle management framework for customized bioprocess solutions

GAMP5 - a lifecycle management framework for customized bioprocess solutions GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),

More information

State of Control Over the Lifecycle and Process Validation (New and Legacy Products)

State of Control Over the Lifecycle and Process Validation (New and Legacy Products) State of Control Over the Lifecycle and Process Validation (New and Legacy Products) Grace McNally Branch Chief (acting), Regulatory Policy and Collaboration Branch FDA/CDER/Office of Compliance ICH Q10,

More information

The Compass Summer 2010 Newsletter of the Southern Regional Chapter Society or Quality Assurance. Data Quality and the Origin of ALCOA

The Compass Summer 2010 Newsletter of the Southern Regional Chapter Society or Quality Assurance. Data Quality and the Origin of ALCOA Data Quality and the Origin of ALCOA Stan W. Woollen Senior Compliance Advisor Stan Woollen and Associates If one does a Google search on the term ALCOA, virtually all of the hits lead to Alcoa Inc. According

More information

CHAPTER 7 QUALITY ASSESSMENT

CHAPTER 7 QUALITY ASSESSMENT CHAPTER 7 QUALITY ASSESSMENT Chapter 7 QUALITY ASSESSMENT 7.1 OVERVIEW OF CBB-SPECIFIC QUALITY ASSURANCE/QUALITY CONTROL PROGRAM An extensive, site-specific Quality Assurance/Quality Control (QA/QC) program

More information

Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003. Change Control

Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003. Change Control Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003 Change Control Wolfgang Schumacher Roche Pharmaceuticals, Basel Agenda Change Control Definitions

More information

T ECHNICAL G UIDE EXPANDING THE GLOBAL KNOWLEDGE BASE FOR COMPLIANCE PROFESSIONALS IN FDA-REGULATED INDUSTRIES. Technical Guide

T ECHNICAL G UIDE EXPANDING THE GLOBAL KNOWLEDGE BASE FOR COMPLIANCE PROFESSIONALS IN FDA-REGULATED INDUSTRIES. Technical Guide T ECHNICAL G UIDE EXPANDING THE GLOBAL KNOWLEDGE BASE FOR COMPLIANCE PROFESSIONALS IN FDA-REGULATED INDUSTRIES. Technical Guide 1 A Practical Guide to Change Control Systems Management... FDA has cited

More information

Process Validation for Medical Devices

Process Validation for Medical Devices Process Validation for Medical Devices Dan O Leary CBA, CQE, CRE, CSSBB, CIRM, LLC 603-209-0600 OmbuEnterprises@msn.com Copyright 2010 by, LLC Process Validation for Medical Devices 1 Instructor Introduction

More information

Quality Assurance QUALITY ASSURANCE PLAN

Quality Assurance QUALITY ASSURANCE PLAN Revision 2 Page 1 of 40 QUALITY ASSURANCE PLAN PLAN APPROVALS: Jeff Shouse Signature on File DIRECTOR OF QUALITY ASSURANCE DIRECTOR OF QUALITY ASSURANCE (signature) DATE Rodney Baltzer Signature on File

More information

Software Validation in Clinical Trial Reporting: Experiences from the Biostatistical & Data Sciences Department

Software Validation in Clinical Trial Reporting: Experiences from the Biostatistical & Data Sciences Department Software Validation in Clinical Trial Reporting: Experiences from the Biostatistical & Data Sciences Department Andrea Baker Senior Programmer GlaxoSmithKline SeUGI 19 Florence May 29-June 1 2001 Introduction

More information

Internal Quality Management System Audit Checklist (ISO9001:2015) Q# ISO 9001:2015 Clause Audit Question Audit Evidence 4 Context of the Organization

Internal Quality Management System Audit Checklist (ISO9001:2015) Q# ISO 9001:2015 Clause Audit Question Audit Evidence 4 Context of the Organization Internal Quality Management System Audit Checklist (ISO9001:2015) Q# ISO 9001:2015 Clause Audit Question Audit Evidence 4 Context of the Organization 4.1 Understanding the organization and its context

More information

Identifying and Resolving GMP Issues for Pharmaceutical Process and Facility Design

Identifying and Resolving GMP Issues for Pharmaceutical Process and Facility Design IVTGXP_April07.qxd 3/19/07 12:59 PM Page 42 Identifying and Resolving GMP Issues for Pharmaceutical Process and Facility Design By The absolute, most important aspects of GMP are to remain in control of

More information

Temperature mapping of storage areas Technical supplement to WHO Technical Report Series, No. 961, 2011

Temperature mapping of storage areas Technical supplement to WHO Technical Report Series, No. 961, 2011 WHO Vaccine Temperature mapping of storage areas Technical supplement to WHO Technical Report Series, No. 961, 2011 Annex 9: Model guidance for the storage and transport of time and temperature sensitive

More information

ICH guideline Q10 on pharmaceutical quality system

ICH guideline Q10 on pharmaceutical quality system September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final

More information

Change Control and Configuration Management

Change Control and Configuration Management ISPE Los Angeles Chapter Change Control and Configuration Management Jerry Anderson JAnderson@Watson.com Implementing the New Part 11 Guidance 1 Bio (or, Who is this guy? ) Director, Watson Corporate Computer

More information

Implementation of ANSI/AAMI/IEC 62304 Medical Device Software Lifecycle Processes.

Implementation of ANSI/AAMI/IEC 62304 Medical Device Software Lifecycle Processes. Implementation of ANSI/AAMI/IEC 62304 Medical Device Software Lifecycle Processes.. www.pharmout.net Page 1 of 15 Version-02 1. Scope 1.1. Purpose This paper reviews the implementation of the ANSI/AAMI/IEC

More information

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants September 1999 Table of contents 1. Foreword...... 2 2. Objective...... 3 3. Scope........ 4 4. Potential residues... 5 5. Current

More information